Literature DB >> 21560060

Aetiopathogenesis of Parkinson's disease.

Anthony H V Schapira1.   

Abstract

Parkinson's disease (PD) is characterised both clinically and pathologically by features that distinguish it from other parkinsonian disorders including, for instance, multiple system atrophy and progressive supranuclear palsy. The aetiologies of PD includes both genetic and environmental influences. Several single gene causes of autosomal dominant and recessive PD have been described. Recent genome-wide association (GWA) studies have identified a number of risk alleles for PD. No specific environmental cause has been defined but several factors have been described which influence the risk for PD. Mitochondrial dysfunction, free radical mediated damage, inflammatory change and proteasomal dysfunction have been thought to play a role in PD pathogenesis. Autophagy is now recognised as an important component of the cell's mechanism for protein turnover and has relevance for PD. There is some convergence and overlap of pathogenetic pathways between environmental and genetic factors. The importance of identifying the molecular and biochemical events that lead to PD lies in the prospect that novel drug targets will emerge and that new compounds will be developed that slow the progression of the disease.

Entities:  

Mesh:

Year:  2011        PMID: 21560060     DOI: 10.1007/s00415-011-6016-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

Review 1.  Neurobiology and treatment of Parkinson's disease.

Authors:  Anthony H V Schapira
Journal:  Trends Pharmacol Sci       Date:  2008-11-29       Impact factor: 14.819

Review 2.  Genetic and environmental factors in the cause of Parkinson's disease.

Authors:  Thomas T Warner; Anthony H V Schapira
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

3.  Etiology of Parkinson's disease.

Authors:  Anthony H V Schapira
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

Review 4.  Mitochondria in the aetiology and pathogenesis of Parkinson's disease.

Authors:  Anthony H V Schapira
Journal:  Lancet Neurol       Date:  2008-01       Impact factor: 44.182

Review 5.  Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease.

Authors:  Anthony H V Schapira
Journal:  Neurology       Date:  2009-02-17       Impact factor: 9.910

6.  Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.

Authors:  A Grünewald; M E Gegg; J-W Taanman; R H King; N Kock; C Klein; A H V Schapira
Journal:  Exp Neurol       Date:  2009-06-03       Impact factor: 5.330

Review 7.  Neuroprotection trials in Parkinson's disease: systematic review.

Authors:  Robert G Hart; Lesly A Pearce; Bernard M Ravina; Toby C Yaltho; John R Marler
Journal:  Mov Disord       Date:  2009-04-15       Impact factor: 10.338

Review 8.  Perspectives on recent advances in the understanding and treatment of Parkinson's disease.

Authors:  A H Schapira; Y Agid; P Barone; P Jenner; M R Lemke; W Poewe; O Rascol; H Reichmann; E Tolosa
Journal:  Eur J Neurol       Date:  2009-08-30       Impact factor: 6.089

Review 9.  The roles of intracellular protein-degradation pathways in neurodegeneration.

Authors:  David C Rubinsztein
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

10.  Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function.

Authors:  Vanessa A Morais; Patrik Verstreken; Anne Roethig; Joél Smet; An Snellinx; Mieke Vanbrabant; Dominik Haddad; Christian Frezza; Wim Mandemakers; Daniela Vogt-Weisenhorn; Rudy Van Coster; Wolfgang Wurst; Luca Scorrano; Bart De Strooper
Journal:  EMBO Mol Med       Date:  2009-05       Impact factor: 12.137

View more
  10 in total

1.  Isolation, culture and long-term maintenance of primary mesencephalic dopaminergic neurons from embryonic rodent brains.

Authors:  Maria Weinert; Tharakeswari Selvakumar; Travis S Tierney; Kambiz N Alavian
Journal:  J Vis Exp       Date:  2015-02-19       Impact factor: 1.355

Review 2.  Calcium and Parkinson's disease.

Authors:  D James Surmeier; Paul T Schumacker; Jaime D Guzman; Ema Ilijic; Ben Yang; Enrico Zampese
Journal:  Biochem Biophys Res Commun       Date:  2016-08-30       Impact factor: 3.575

3.  Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects.

Authors:  Asad A Aboud; Andrew M Tidball; Kevin K Kumar; M Diana Neely; Kevin C Ess; Keith M Erikson; Aaron B Bowman
Journal:  Neurotoxicology       Date:  2012-10-22       Impact factor: 4.294

Review 4.  Integrating pathways of Parkinson's disease in a molecular interaction map.

Authors:  Kazuhiro A Fujita; Marek Ostaszewski; Yukiko Matsuoka; Samik Ghosh; Enrico Glaab; Christophe Trefois; Isaac Crespo; Thanneer M Perumal; Wiktor Jurkowski; Paul M A Antony; Nico Diederich; Manuel Buttini; Akihiko Kodama; Venkata P Satagopam; Serge Eifes; Antonio Del Sol; Reinhard Schneider; Hiroaki Kitano; Rudi Balling
Journal:  Mol Neurobiol       Date:  2013-07-07       Impact factor: 5.590

5.  Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activity.

Authors:  Sarah J Annesley; Sui T Lay; Shawn W De Piazza; Oana Sanislav; Eleanor Hammersley; Claire Y Allan; Lisa M Francione; Minh Q Bui; Zhi-Ping Chen; Kevin R W Ngoei; Flora Tassone; Bruce E Kemp; Elsdon Storey; Andrew Evans; Danuta Z Loesch; Paul R Fisher
Journal:  Dis Model Mech       Date:  2016-09-16       Impact factor: 5.758

6.  The Hyperpolarization-Activated Current Determines Synaptic Excitability, Calcium Activity and Specific Viability of Substantia Nigra Dopaminergic Neurons.

Authors:  Carmen Carbone; Alessia Costa; Gustavo Provensi; Guido Mannaioni; Alessio Masi
Journal:  Front Cell Neurosci       Date:  2017-06-28       Impact factor: 5.505

Review 7.  Dissecting the role of Engrailed in adult dopaminergic neurons--Insights into Parkinson disease pathogenesis.

Authors:  Hocine Rekaik; François-Xavier Blaudin de Thé; Alain Prochiantz; Julia Fuchs; Rajiv L Joshi
Journal:  FEBS Lett       Date:  2015-10-13       Impact factor: 4.124

Review 8.  Parkinson's disease related pain: a review of recent findings.

Authors:  A Truini; M Frontoni; G Cruccu
Journal:  J Neurol       Date:  2012-11-23       Impact factor: 4.849

Review 9.  Neuroprotective Transcription Factors in Animal Models of Parkinson Disease.

Authors:  François-Xavier Blaudin de Thé; Hocine Rekaik; Alain Prochiantz; Julia Fuchs; Rajiv L Joshi
Journal:  Neural Plast       Date:  2015-12-31       Impact factor: 3.599

10.  Association of periodic limb movements during sleep and Parkinson disease: A retrospective clinical study.

Authors:  Shang-Rung Hwang; Sheng-Wei Hwang; Jin-Cherng Chen; Juen-Haur Hwang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.